来自MSN51 分钟
Moderna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full ...
Biotechnology company Moderna (NASDAQ:MRNA) in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other ...
来自MSN51 分钟
TreeHouse Foods (NYSE:THS) Posts Q4 Sales In Line With Estimates But Full-Year Sales ...
Private label food company TreeHouse Foods (NYSE:THS) in Q4 CY2024, but sales were flat year on year at $905.7 million. On ...